AA
Alan H Auerbach
President and CEODirector10% Owner

Alan H Auerbach insider trades: Puma Biotechnology (PBYI) stock sales

President and CEO, Puma Biotechnology Last trade Jul 6, 2026 94 Form 4 filings
$569K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
63
Open-market trades
since 2017
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Alan reports to the SEC

Open-market buys and sales

63 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 6, 2026PBYI↓ Sell$364K
Jan 7, 2026PBYI↓ Sell$205K
Jul 9, 2025PBYI↓ Sell$167K
Jan 2, 2025PBYI↓ Sell$107K
Jul 17, 2024PBYI↓ Sell$81K
Jul 2, 2024PBYI↓ Sell$62K
Jan 3, 2024PBYI↓ Sell$186K
Jul 3, 2023PBYI↓ Sell$201K
Jan 3, 2023PBYI↓ Sell$114K
Dec 2, 2022PBYI↓ Sell$6K
Nov 2, 2022PBYI↓ Sell$3K
Oct 3, 2022PBYI↓ Sell$3K
Sep 2, 2022PBYI↓ Sell$3K
Aug 2, 2022PBYI↓ Sell$4K
Jul 5, 2022PBYI↓ Sell$69K
Jun 2, 2022PBYI↓ Sell$2K
May 3, 2022PBYI↓ Sell$3K
Apr 4, 2022PBYI↓ Sell$4K
Mar 2, 2022PBYI↓ Sell$3K
Feb 2, 2022PBYI↓ Sell$3K
Jan 3, 2022PBYI↓ Sell$73K
Dec 2, 2021PBYI↓ Sell$5K
Nov 2, 2021PBYI↓ Sell$10K
Oct 4, 2021PBYI↓ Sell$11K
Sep 2, 2021PBYI↓ Sell$13K
Aug 2, 2021PBYI↓ Sell$13K
Jul 2, 2021PBYI↓ Sell$47K
Jun 2, 2021PBYI↓ Sell$19K
May 3, 2021PBYI↓ Sell$16K
Apr 5, 2021PBYI↓ Sell$16K
Mar 2, 2021PBYI↓ Sell$13K
Feb 2, 2021PBYI↓ Sell$15K
Jan 4, 2021PBYI↓ Sell$186K
Dec 2, 2020PBYI↓ Sell$4K
Nov 2, 2020PBYI↓ Sell$3K
Oct 2, 2020PBYI↓ Sell$4K
Sep 2, 2020PBYI↓ Sell$3K
Aug 3, 2020PBYI↓ Sell$4K
Jul 2, 2020PBYI↓ Sell$28K
Jun 2, 2020PBYI↓ Sell$4K
May 4, 2020PBYI↓ Sell$3K
Apr 2, 2020PBYI↓ Sell$3K
Mar 2, 2020PBYI↓ Sell$4K
Feb 3, 2020PBYI↓ Sell$3K
Jan 2, 2020PBYI↓ Sell$50K
Dec 2, 2019PBYI↓ Sell$5K
Nov 4, 2019PBYI↓ Sell$4K
Oct 2, 2019PBYI↓ Sell$5K
Sep 4, 2019PBYI↓ Sell$5K
Aug 2, 2019PBYI↓ Sell$5K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PBYI insiders

Open-market trades in the last 12 months

About Alan H Auerbach's insider trades

Alan H Auerbach is President and CEO at Puma Biotechnology (PBYI). Since Jan 20, 2017, Alan has reported no open-market purchases and 63 sales worth $5.9M on SEC Form 4. In the last 12 months: 2 sales ($569K).

Their filings also include grants and awards (30 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PBYI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.